학술논문

Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study
Document Type
Article
Source
In Blood 6 April 2023 141(14):1675-1684
Subject
Clinical Trials and Observations
Immunobiology and Immunotherapy
Free Research Articles
Lymphoid Neoplasia
Language
ISSN
0006-4971